Harvard Bioscience Inc.

NASDAQ: HBIO · Real-Time Price · USD
0.48
-0.05 (-9.06%)
At close: Aug 11, 2025, 3:59 PM

Harvard Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
5.55M 4.11M 4.57M 4.05M 4.25M 4.28M 5.34M 4.32M 3.79M 4.51M 5.14M 4.26M 5.43M 7.82M 5.55M 6.24M 5.82M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 34K 1.7M n/a n/a n/a n/a -333K n/a n/a n/a -205K n/a n/a n/a
Other Long-Term Assets
3.52M 2.83M 2.92M 3.24M 4.79M 6.04M 12.57M 11.66M 13.45M 13.6M 14.32M 8.69M 5.26M 12.27M 7.8M 810K 812K
Receivables
13.48M 14.87M 12.83M 12.49M 15.31M 16.1M 14.98M 16.9M 17.74M 16.7M 15.02M 17.85M 20.27M 21.83M 18.34M 17.39M 17.07M
Inventory
22.82M 23.25M 25.99M 25.13M 24.14M 24.72M 25.82M 26.09M 26.86M 26.44M 26.12M 29.34M 28.71M 27.59M 25.98M 24.71M 22.68M
Other Current Assets
3.06M 2.9M 3.4M 4.77M 4.45M 3.94M 4.34M 5.3M 4.06M 3.47M 5.54M 5.06M 5.03M 4.34M 5.82M 5.22M 3.66M
Total Current Assets
44.9M 45.12M 46.79M 46.43M 48.15M 49.04M 50.49M 52.62M 52.45M 51.12M 51.82M 56.5M 59.45M 61.58M 55.69M 53.56M 49.22M
Property-Plant & Equipment
12.29M 11.24M 11.74M 9.18M 8.85M 8.75M 3.36M 3.49M 3.42M 3.37M 3.56M 9.63M 10.1M 3.42M 3.45M 10.67M 11.11M
Goodwill & Intangibles
19.09M 67.46M 69.78M 70.07M 71.38M 73.1M 73.32M 75.13M 76.26M 77.27M 77.31M 80.45M 83.23M 85.07M 86.93M 88.93M 90.11M
Total Long-Term Assets
34.9M 81.53M 84.45M 82.48M 85.01M 88.33M 89.25M 90.28M 93.13M 94.24M 95.19M 98.78M 98.6M 100.76M 98.19M 100.41M 102.03M
Total Assets
79.8M 126.64M 131.24M 128.91M 133.16M 137.37M 139.74M 142.9M 145.58M 145.36M 147.01M 155.27M 158.04M 162.34M 153.87M 153.97M 151.25M
Account Payables
4.81M 4.79M 5.28M 5.71M 6.04M 5.55M 6.27M 4.72M 5.98M 6.45M 5.88M 6.81M 6.22M 4.91M 5.62M 7.49M 6.42M
Deferred Revenue
3.43M 5.09M n/a 5.12M 5.94M 7.71M 4M 3.83M 4.12M 3.37M 3.64M 3.61M 3.96M 4.27M 3.62M 3.67M 3.64M
Short-Term Debt
35.96M 36.96M 3.61M 3.72M 4.92M 7.28M 3.47M 3.22M 2.97M 3.81M 2.72M 4.83M 4.87M 3.23M 2.47M 4.28M 4.03M
Other Current Liabilities
9.99M 8.25M 13.86M 9.38M 13.52M 12.3M 4.96M 5.25M 8.02M 7.49M 3.91M 5.94M 9.89M 4.49M 5.43M 5.76M 3.98M
Total Current Liabilities
55.6M 54.96M 22.75M 22.62M 25.68M 26.54M 24.2M 22.94M 23.22M 23.25M 21.36M 23.35M 27.23M 25.32M 23.51M 23.27M 20.72M
Long-Term Debt
n/a n/a 34.25M 31.96M 31.89M 30.7M 35.27M 38.2M 41.08M 43.01M 46.53M 45.76M 46.24M 45.09M 42.74M 40.92M 41.6M
Other Long-Term Liabilities
1.42M 1.25M 1.5M 1.61M 1.45M 1.48M 892K 1.05M 1.45M 1.01M 420K 418K 598K 486K 2.47M 2.54M 2.85M
Total Long-Term Liabilities
9.36M 8.35M 43.17M 39.04M 38.67M 37.75M 41.24M 44.57M 48.02M 49.89M 53.67M 54.41M 54.44M 53.63M 53.48M 52M 53.42M
Total Liabilities
64.97M 63.3M 65.92M 61.66M 64.35M 64.29M 65.45M 67.51M 71.24M 73.14M 75.03M 77.77M 81.67M 78.94M 76.98M 75.27M 74.13M
Total Debt
44.61M 44.49M 45.69M 41.45M 41.36M 42.77M 38.74M 41.42M 44.05M 46.82M 49.25M 56.4M 57.27M 48.33M 45.21M 52.17M 52.79M
Common Stock
442K 441K 436K 436K 434K 434K 457K 457K 455K 454K 453K 453K 452K 452K 451K 451K 448K
Retained Earnings
-208.35M -158.01M -158.03M -153.23M -150.3M -145.6M -143.79M -142.55M -141.57M -142.19M -140.52M -137.12M -139.55M -132.67M -133.63M -133.47M -133.06M
Comprehensive Income
-14.36M -15.67M -13.06M -14.87M -14.77M -14.19M -15.28M -14.05M -14.65M -15.05M -16.18M -13.24M -10.73M -10.03M -15M -13.87M -14.39M
Shareholders Equity
14.84M 63.34M 65.32M 67.25M 68.81M 73.07M 74.29M 75.39M 74.34M 72.22M 71.98M 77.5M 76.38M 83.4M 76.89M 78.7M 77.11M
Total Investments
n/a n/a n/a 34K 1.7M n/a n/a n/a n/a -333K n/a n/a n/a -205K n/a n/a n/a